NCT01003795

Promus - Registry Experience at the Washington Hospital Center, Drug-eluting Stent (DES)

P-REWARDS (Promus - Registry Experience at the Washington Hospital Center, DES)

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Medstar Health Research Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Single-center registry of patients treated with at least one Promus, everolimus-eluting, Stent, with the primary objective to assess clinical success and safety at 30 days, 6 months and 1 year post-implantation.

Detailed description

Interventional cardiology was revolutionized by the invention of stents, initially with the bare-metal stents (BMS) and recently with the drug-eluting stents (DES). The everolimus eluting stents have shown very promising results in randomized clinical trials, demonstrating a reduction of clinical and angiographic restenosis in comparison to BMS, and comparable clinically-driven target lesion revascularization rates in comparison with sirolimus-eluting stents. While registry data is available from outside of the United States, it will be important to collect "real-world" data regarding the stent usage and outcomes in the United States. In this study we propose to follow patients who received at least one Promus® Stent for at least 1 year post initial stent implantation.

Conditions

• Coronary Artery Disease

Timeline

• Start date: 2009-10-01
• Primary completion: 2012-07-01
• Completion: 2013-10-01
• First posted: 2009-10-29
• Last updated: 2020-10-19

Locations

1 site across 1 country: United States